Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
3 Biotech Stocks Poised for a Comeback After Last Week's Market Meltdown
07:30am, Tuesday, 13'th Aug 2024
Due to their sometimes speculative nature, biotech stocks are especially sensitive to broader market corrections like the one experienced last week. This can be exceptionally stressful for investors,
Novo Nordisk Just Hit 3 Snags in a Row. Is Its Stock Still a Buy?
07:30am, Tuesday, 13'th Aug 2024
Novo Nordisk has had a somewhat rough summer. Two different interactions with regulators didn't go its way.
Is Novo Nordisk (NVO) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:46pm, Monday, 12'th Aug 2024
Novo Nordisk (NVO) could produce exceptional returns because of its solid growth attributes.
Is It Worth Investing in Novo Nordisk (NVO) Based on Wall Street's Bullish Views?
10:36am, Monday, 12'th Aug 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Novo Nordisk A/S – Share repurchase programme
08:31am, Monday, 12'th Aug 2024
Bagsværd, Denmark, 12 August 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Counc
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
08:04am, Monday, 12'th Aug 2024
Bagsværd, Denmark, 12 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated pe
Weight Loss Stocks Could Become Alzheimer's Drugs Stocks. Here's Why That's Bullish for Novo Nordisk
06:30am, Monday, 12'th Aug 2024
One of Novo Nordisk's medicines could be helpful for treating Alzheimer's disease. A lot of questions need answering before it'll make any new revenue.
Novo Nordisk: Reality Is Starting To Set In
08:30am, Saturday, 10'th Aug 2024
Novo Nordisk A/S investors recently endured a rare bear market after the stock topped out in June 2024. Novo Nordisk faces heightened competitive risks from arch-rival Eli Lilly, as seen in Eli Lilly'
Novo Nordisk: How Concerning Is Wegovy's Growth Come-Off?
04:56am, Saturday, 10'th Aug 2024
Novo Nordisk's sharp price drop following its Q2 2024 results is attributed particularly to slowing sales growth of Wegovy, calling for a closer look at the hugely popular treatment's numbers. A comb
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
02:29pm, Friday, 09'th Aug 2024
Bagsværd, Denmark, 9 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated per
What Eli Lilly, Novo Nordisk earnings show about GLP-1 sales
01:07pm, Friday, 09'th Aug 2024
Recent earnings from Eli Lilly and Company (LLY) and Novo Nordisk (NVO) highlight the demand for GLP-1 drugs and why not all GLP-1 providers may be created equal. Yahoo Finance senior healthcare repor
Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings
09:27am, Friday, 09'th Aug 2024
Novo Nordisk NYSE: NVO is the world's second-largest pharmaceutical company, with a market capitalization of $538 billion. The Danish firm's shares have performed well so far in 2024, returning 23%, o
It's Too Soon to Buy the Dip in Weight Loss Drugmakers
07:00am, Friday, 09'th Aug 2024
Obesity drugmakers like Eli Lilly NYSE: LLY and Novo Nordisk NYSE: NVO were not immune to the broad market sell-off sparked by the June CPI report, but investors looking to get into these names should
Eli Lilly Narrows Gap with Novo Nordisk
01:59pm, Thursday, 08'th Aug 2024
Madison Muller, Bloomberg Health Reporter, discusses Eli Lilly earnings on Bloomberg Intelligence. -------- More on Bloomberg Television and Markets Like this video?
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
12:54pm, Thursday, 08'th Aug 2024
Bagsværd, Denmark, 8 August 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated per
